News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,349 Results
Type
Article (87520)
Company Profile (807)
Press Release (774000)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233090)
Career Advice (4140)
Deals (39809)
Drug Delivery (140)
Drug Development (91278)
Employer Resources (203)
FDA (18296)
Job Trends (17406)
News (397476)
Policy (39928)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56980)
ALS (147)
Alzheimer's disease (1689)
Antibody-drug conjugate (ADC) (262)
Approvals (18330)
Artificial intelligence (509)
Autoimmune disease (98)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (520)
Cancer (4113)
Cardiovascular disease (357)
Career advice (3562)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (703)
Cervical cancer (33)
Clinical research (75738)
Collaboration (1436)
Company closure (4)
Compensation (952)
Complete response letters (62)
COVID-19 (2962)
CRISPR (84)
C-suite (613)
Cystic fibrosis (141)
Data (4799)
Decentralized trials (2)
Denatured (64)
Depression (113)
Diabetes (461)
Diagnostics (7102)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (242)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (99101)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133321)
Executive appointments (998)
FDA (20864)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1295)
Gene editing (178)
Generative AI (52)
Gene therapy (561)
GLP-1 (1033)
Government (5391)
Grass and pollen (8)
Guidances (372)
Healthcare (20938)
HIV (49)
Huntington's disease (41)
IgA nephropathy (64)
Immunology and inflammation (255)
Immuno-oncology (22)
Indications (58)
Infectious disease (3212)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (197)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10150)
Liver cancer (92)
Longevity (13)
Lung cancer (591)
Lymphoma (271)
Machine learning (32)
Management (66)
Manufacturing (667)
MASH (145)
Medical device (14904)
Medtech (14930)
Mergers & acquisitions (22777)
Metabolic disorders (1180)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (236)
Neuropsychiatric disorders (63)
Neuroscience (2754)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (60)
Obesity (569)
Opinion (315)
Ovarian cancer (140)
Pain (172)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (32)
Patents (428)
Patient recruitment (334)
Peanut (57)
People (66339)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23358)
Phase II (32860)
Phase III (24789)
Pipeline (2825)
Policy (301)
Postmarket research (3554)
Preclinical (10542)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (701)
Real estate (7422)
Recruiting (79)
Regulatory (28114)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (160)
Service/supplier (30)
Sickle cell disease (82)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1060)
Venture capital (68)
Weight loss (403)
Women's health (60)
Worklife (21)
Date
Today (90)
Last 7 days (747)
Last 30 days (2840)
Last 365 days (33460)
2025 (27885)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (308)
Arkansas (14)
Asia (51059)
Australia (8976)
California (9757)
Canada (2918)
China (942)
Colorado (411)
Connecticut (433)
Delaware (279)
Europe (117320)
Florida (1437)
Georgia (323)
Hawaii (3)
Idaho (67)
Illinois (827)
India (55)
Indiana (481)
Iowa (20)
Japan (336)
Kansas (127)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1307)
Massachusetts (7299)
Michigan (318)
Minnesota (580)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2710)
New Mexico (32)
New York (2641)
North Carolina (1430)
North Dakota (10)
Northern California (4466)
Ohio (308)
Oklahoma (22)
Oregon (51)
Pennsylvania (2023)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (51)
South Dakota (1)
Southern California (3722)
Tennessee (152)
Texas (1535)
United States (35940)
Utah (294)
Virginia (253)
Washington D.C. (84)
Washington State (836)
West Virginia (4)
Wisconsin (101)
Wyoming (2)
There are 862,349 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting
November 3, 2025
·
4 min read
Press Releases
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
November 3, 2025
·
3 min read
Press Releases
Quest Diagnostics to Speak at Citi’s 2025 Global Healthcare Conference
November 3, 2025
·
1 min read
Press Releases
U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
November 3, 2025
·
13 min read
Press Releases
Solventum to Participate in the 2025 Stifel Healthcare Conference
November 3, 2025
·
1 min read
Press Releases
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025
·
4 min read
Press Releases
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
November 3, 2025
·
2 min read
Press Releases
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 3, 2025
November 3, 2025
·
1 min read
Press Releases
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
November 3, 2025
·
6 min read
Press Releases
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU
November 3, 2025
·
9 min read
1 of 86,235
Next
